2-165888388-T-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_024753.5(TTC21B):c.3350A>C(p.Gln1117Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,613,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1117L) has been classified as Uncertain significance.
Frequency
Consequence
NM_024753.5 missense
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 12Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- asphyxiating thoracic dystrophy 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Jeune syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TTC21B | NM_024753.5 | c.3350A>C | p.Gln1117Pro | missense_variant | Exon 25 of 29 | ENST00000243344.8 | NP_079029.3 | |
| TTC21B | XM_017004967.2 | c.3350A>C | p.Gln1117Pro | missense_variant | Exon 25 of 28 | XP_016860456.1 | ||
| TTC21B | XM_047445870.1 | c.2696A>C | p.Gln899Pro | missense_variant | Exon 21 of 25 | XP_047301826.1 | ||
| TTC21B | XM_011511871.4 | c.2600A>C | p.Gln867Pro | missense_variant | Exon 20 of 24 | XP_011510173.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TTC21B | ENST00000243344.8 | c.3350A>C | p.Gln1117Pro | missense_variant | Exon 25 of 29 | 1 | NM_024753.5 | ENSP00000243344.7 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251246 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461530Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727096 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Asphyxiating thoracic dystrophy 4;C3151186:Nephronophthisis 12 Uncertain:1
- -
Jeune thoracic dystrophy;C0687120:Nephronophthisis Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1117 of the TTC21B protein (p.Gln1117Pro). This variant is present in population databases (rs148631747, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. ClinVar contains an entry for this variant (Variation ID: 572325). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at